Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Atavistik Bio, Inc
Eli Lilly and Company
Intuitive Surgical
Stemline Therapeutics, Inc.
AstraZeneca
Incepta Pharmaceuticals Ltd
Hoffmann-La Roche
RemeGen Co., Ltd.
Novartis
TaiHao Medical Inc.
TaiHao Medical Inc.
BioNumerik Pharmaceuticals, Inc.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Novartis
Novartis
Pfizer
Merck Sharp & Dohme LLC